GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Equity-to-Asset

Ajanta Pharma (BOM:532331) Equity-to-Asset : 0.77 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ajanta Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹35,674 Mil. Ajanta Pharma's Total Assets for the quarter that ended in Mar. 2024 was ₹46,384 Mil. Therefore, Ajanta Pharma's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.77.

The historical rank and industry rank for Ajanta Pharma's Equity-to-Asset or its related term are showing as below:

BOM:532331' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.72   Med: 0.8   Max: 0.85
Current: 0.77

During the past 13 years, the highest Equity to Asset Ratio of Ajanta Pharma was 0.85. The lowest was 0.72. And the median was 0.80.

BOM:532331's Equity-to-Asset is ranked better than
77.42% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BOM:532331: 0.77

Ajanta Pharma Equity-to-Asset Historical Data

The historical data trend for Ajanta Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Equity-to-Asset Chart

Ajanta Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.79 0.81 0.72 0.77

Ajanta Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 - 0.79 - 0.77

Competitive Comparison of Ajanta Pharma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajanta Pharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's Equity-to-Asset falls into.



Ajanta Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ajanta Pharma's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=35673.6/46383.9
=0.77

Ajanta Pharma's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=35673.6/46383.9
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ajanta Pharma  (BOM:532331) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Ajanta Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajanta Pharma (BOM:532331) Business Description

Traded in Other Exchanges
Address
Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines